Total Voting Rights

RNS Number : 4498W
Dalata Hotel Group PLC
01 August 2018
 

 

 

Total Voting Rights

 

 

ISE: DHG                              LSE: DAL

 

 

In conformity with Regulation 20 of the Transparency (Directive 2004/109/EC) Regulations 2007, Dalata Hotel Group plc announces that:

As of 01 August 2018, Dalata Hotel Group plc's share capital consists of 184,277,078 Ordinary Shares of nominal value €0.01 each.  Dalata Hotel Group plc does not hold any Ordinary Shares in treasury.  Therefore, the total number of voting rights in Dalata Hotel Group plc is 184,277,078.

The above figure may be used by shareholders as a denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Dalata Hotel Group plc under the Transparency (Directive 2004/109/EC) Regulations 2007.

 

ENDs

 

 

Contacts

 

Dalata Hotel Group plc

Sean McKeon, Company Secretary

T: +353 1 206 9400

E: smckeon@dalatahotelgroup.com

 

 

 

 

 

 

About Dalata

Dalata Hotel Group plc is Ireland's largest hotel operator with a growing presence in the United Kingdom. The Group's current portfolio consists of 39 hotels with over 8,200 rooms and an additional 2,342 rooms are currently being developed. Dalata successfully operates Ireland's two largest hotel brands, Clayton Hotels and Maldron Hotels across Ireland and the UK, as well as managing a small portfolio of partner properties. 28 of the hotels are owned by Dalata, nine hotels are operated under lease agreements and two are operated under management agreements. For the full year 2017, Dalata reported revenue of €348.5 million and a profit after tax of €68.3 million. Dalata is listed on the Main Market of Euronext Dublin (DHG) and the London Stock Exchange (DAL).

For further information visit: www.dalatahotelgroup.com

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRMMGGRRMGGRZG
UK 100

Latest directors dealings